The active metabolite of leflunomide, A77 1726, interferes with dendritic cell function

Benzer Materyaller

• Purification of human dihydro-orotate dehydrogenase and its inhibition by A77 1726, the active metabolite of leflunomide.
  Yazar:: Bruneau, J M, ve diğerleri
  Baskı/Yayın Bilgisi: (1998)
• The active metabolite of leflunomide, A77-1726, increases proliferation of human synovial fibroblasts in presence of IL-1β
  Yazar:: Magne, D, ve diğerleri
  Baskı/Yayın Bilgisi: (2004)
• Suppressive effect of leflunomide metabolite (A77 1726) on metalloproteinase production in IL-1β stimulated rheumatoid synovial fibroblasts
  Yazar:: MIGITA, K, ve diğerleri
  Baskı/Yayın Bilgisi: (2004)
• The active metabolite of leflunomide, A77 1726, increases the production of IL-1 receptor antagonist in human synovial fibroblasts and articular chondrocytes
  Yazar:: Palmer, Gaby, ve diğerleri
  Baskı/Yayın Bilgisi: (2004)
• Therapeutic drug monitoring of A77 1726, the active metabolite of leflunomide: serum concentrations predict response to treatment in patients with rheumatoid arthritis
  Yazar:: van Roon, E N, ve diğerleri
  Baskı/Yayın Bilgisi: (2005)